UMB Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
2,303
-1,094
| -32% | -$487K | 0.02% | 320 |
|
|
2025
Q1 | $1.65M | Sell |
3,397
-1,666
| -33% | -$808K | 0.03% | 254 |
|
|
2024
Q4 | $2.04M | Sell |
5,063
-131
| -3% | -$52.8K | 0.03% | 235 |
|
|
2024
Q3 | $2.42M | Sell |
5,194
-32
| -0.6% | -$14.9K | 0.04% | 221 |
|
|
2024
Q2 | $2.45M | Sell |
5,226
-1,166
| -18% | -$547K | 0.04% | 221 |
|
|
2024
Q1 | $2.67M | Sell |
6,392
-30,103
| -82% | -$12.6M | 0.04% | 211 |
|
|
2023
Q4 | $14.8M | Sell |
36,495
-2,109
| -5% | -$858K | 0.22% | 94 |
|
|
2023
Q3 | $13.4M | Sell |
38,604
-3,798
| -9% | -$1.32M | 0.22% | 99 |
|
|
2023
Q2 | $14.9M | Buy |
42,402
+300
| +0.7% | +$106K | 0.23% | 99 |
|
|
2023
Q1 | $13.3M | Sell |
42,102
-1,306
| -3% | -$411K | 0.21% | 107 |
|
|
2022
Q4 | $12.5M | Buy |
43,408
+1,042
| +2% | +$301K | 0.2% | 111 |
|
|
2022
Q3 | $12.3M | Buy |
42,366
+21,362
| +102% | +$6.19M | 0.21% | 110 |
|
|
2022
Q2 | $5.92M | Buy |
21,004
+20,829
| +11,902% | +$5.87M | 0.09% | 175 |
|
|
2022
Q1 | $46K | Buy |
175
+1
| +0.6% | +$263 | ﹤0.01% | 993 |
|
|
2021
Q4 | $38K | Buy |
+174
| New | +$38K | ﹤0.01% | 1073 |
|